Skip to content
SmartFigure
HDFC Mutual Fund

HDFC Pharma and Healthcare Fund

HDFC Mutual Fund · Direct plan · Growth

1-year returns
27.3%
NAV
₹22.80
▲ 1.15% · 18 Sept 2026
Fund size
₹3,311 Cr
Expense ratio
1.11%
a year
Minimum SIP
₹100

Figures are for the Direct plan. The Regular plan, bought through a distributor, is at ₹22.02 and has returned 25.86% over a year.

Returns, and where it stands

Against the average sectoral / thematic fund, and its place among them. Anything longer than a year is a yearly rate.

PeriodThis fundCategoryRank
1 year27.3%5.2%ahead4 of 221
Every period, and the Regular plan →
PeriodDirectRegular
1 month2.3%2.2%
3 months11.7%11.4%
6 months28.7%28%
1 year27.3%25.9%
2 yearsp.a.18.6%17.2%

Figures are for the Direct plan, and the rank compares it against the same plan of its peers, best first. Based on NAV history from Oct 2023.

Plan

NAV history

▲ 27.29% in the last 1Y

16.919.822.718 Sept 202520 Mar 202618 Sept 2026

Hover or tap the chart for the NAV on any date. Past NAVs are adjusted for unit splits.

If you had invested in this fund

Investment type
years
Total invested
₹1,20,000
Gain
₹35,556
XIRR (per year)
27.26%
Value today
₹1,55,556

24 monthly instalments from 20 Sept 2024, valued at the latest NAV. Past returns do not guarantee future returns.

What the ride has been like

Worked out from this fund's own NAV history, not a rating.

How bumpy
14% a year
1.6% less than the category average — the steadier side
Worst fall so far
−14.9%
Jan 2025 to Feb 2025.
Years that made money
100%
Of every one-year stretch it has been through.

Fund details

Minimum lumpsum
₹100
Minimum top-up
₹100
Lock-in
None
Plan started
4 Oct 2023
Portfolio turnover
0.37x
Expense ratio
1.11%
as of 31 Jul 2026

Managed by Dhruv Muchhal, Nikhil Mathur

Direct plan figures, last checked on 20 Sept 2026. Exit load and the scheme's benchmark are in thescheme document.

How it compares

HDFC Pharma and Healthcare Fund against other funds in the Sectoral / Thematic Fund category
Fund1Y3Y5YExpenseFund size
Nippon India Taiwan Equity Fund118%61.43%1.24%₹1,128 Cr
HDFC Defence Fund21.09%37.07%0.9%₹11,478 Cr
HDFC Transportation and Logistics Fund7.35%24.8%1.09%₹2,116 Cr
SBI Healthcare Opportunities Fund20.88%24.31%18.52%1.02%₹5,796 Cr
UTI - Healthcare Fund16.82%24.15%16.09%1.28%₹1,444 Cr
LIC MF Infrastructure Fund8.97%23.9%21.88%1.35%₹1,174 Cr
HDFC Pharma and Healthcare Fund27.29%1.11%₹3,311 Cr

About HDFC Pharma and Healthcare Fund

HDFC Pharma and Healthcare Fund is a sectoral / thematic fund managed by HDFC Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

The scheme's stated objective, as published by HDFC Mutual Fund.

The NAV (net asset value) is the price of one unit of the fund. It is published by the fund house every business day and changes with the value of the fund's holdings. The Growth option reinvests all gains, so its NAV reflects the fund's total return.

Tax on your gains

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Work out what you would owe with the capital gains tax calculator.

Every plan and option, with scheme codes
PlanOptionNAVScheme code
DirectGrowth Option₹22.803152082
DirectIDCW Option₹22.803152081
RegularGrowth Option₹22.017152084
RegularIDCW Option₹22.017152083

Frequently asked questions

What is the NAV of HDFC Pharma and Healthcare Fund today?

The NAV of HDFC Pharma and Healthcare Fund (Direct plan, Growth) is ₹22.803 and the Regular plan NAV is ₹22.017, as of 18 Sept 2026.

What returns has HDFC Pharma and Healthcare Fund given?

Over the last year the Direct plan returned 27.29%. Past returns do not guarantee future returns.

What is the expense ratio of HDFC Pharma and Healthcare Fund?

The Direct plan charges 1.11% a year, as disclosed on 31 Jul 2026. The fee is already taken out of the NAV, so the returns above are what you keep.

What is the minimum SIP amount in HDFC Pharma and Healthcare Fund?

You can start a monthly SIP with ₹100, or invest a lump sum of ₹100 or more.

How much has HDFC Pharma and Healthcare Fund fallen in the past?

Its deepest fall was 14.9% from 2 Jan 2025 to 28 Feb 2025. Of every one-year stretch in its history, 100% ended in a gain.

Which category does HDFC Pharma and Healthcare Fund belong to?

It is a Sectoral / Thematic Fund from HDFC Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.

What is the difference between the Direct and Regular plan?

Both invest in the same portfolio. The Direct plan is bought straight from the fund house or a direct platform and has a lower expense ratio because no distributor commission is paid, so its NAV grows slightly faster over time.

How are gains from HDFC Pharma and Healthcare Fund taxed?

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Source: NAVs published by the fund house through AMFI. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.